This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The primary health outcome was the change in the probability of newborn mortality. This was estimated by regression, where the probability was one if the newborn died during the neonatal period. The primary explanatory variable was LOS (in hours). LOS was estimated using the known hour of the birth and the number of nights stayed, along with assumptions about discharge.
The authors controlled for the influences of the marital status of the mother, her Medicaid status, whether she was multiparous, whether she was younger 18 years of age, the newborn's gender, and the newborn's race.
The authors stratified the sample by mode of delivery in order to control for vaginal or Caesarean birth.
To predict the impact of LOS on infant mortality, the authors measured the actual estimated LOS, and the LOS expected if all mothers and newborns used at least the time allowed under the LOS mandate.
Effectiveness results
The coefficients from the logistic regression were as follows: The mean increase in estimated LOS to conform with the LOS mandate was 15 hours.
The mean predicted probability of neonatal death fell from 0.039% using the estimated actual LOS to 0.025% when assuming an increased LOS.
Clinical conclusions
The authors did not draw clinical conclusions independently from the cost conclusions.
Modelling
A logistic regression model was used to predict the impact of changes in LOS on the probability of newborn mortality.
Measure of benefits used in the economic analysis
The authors estimated the number of lives saved from increased LOS by considering the change in the predicted probability of death, and the estimated life-years gained per life saved. A base-case discount rate of 3% was used to
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Direct costs
The costs were estimated from a societal perspective. The three categories of cost considered were hospital input, physician labour and postdischarge professional care. The authors did not generate a single point estimate, but instead defined a range between which they expected the costs to fall. This gave them an upper and lower bound analysis. The costs were estimated using actual data taken from surveys, a randomised controlled trial and administrative records. The unit costs were reported separately. The quantity of resources was measured for postpartum stays between 1989 and 1990. The price year was 2000. The authors did not discount the costs, as the costs of increased postpartum LOS were incurred within the first few weeks after birth.
Statistical analysis of costs
The 95% cost-effectiveness ratios were developed using bootstrapping with 1,000 samples. A statistical analysis was performed using Stata software (version 7.0).
Indirect Costs
Although the authors reported that a societal perspective was adopted, it was unclear whether any indirect costs were included in the analysis.
Currency

US dollars ($).
Sensitivity analysis
The nature of the cost analysis was such that the lower and upper bound estimates for all cost categories provided a form of sensitivity analysis.
Estimated benefits used in the economic analysis
The authors did not report the estimated benefits independently from the costs (see Synthesis of Costs and Benefits).
Cost results
For the lower bound analysis, the mean projected increase in the total direct medical costs was $84 (standard deviation 75; 25th percentile 3; 75th percentile 130).
For the upper bound analysis, the mean projected increase in the total direct medical costs was $401 (standard deviation 359; 25th percentile 18; 75th percentile 593).
Synthesis of costs and benefits
The incremental cost per discounted life-year gained was $19,800 (95% CI: 11,600 -61,300) for the lower bound analysis and $94,800 (95% CI: 55,200 -286,800) for the upper bound analysis.
The results were moderately sensitive to an indicator for mode of delivery. The results were very sensitive to the definition of the time period over which newborn deaths were considered, and the discount rate.
